Investments
14Portfolio Exits
2
Want to inform investors similar to Paratus Investment about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Paratus Investment News
May 2, 2022
Genome Insight, a San Diego, CA-based Whole Genome Sequence analysis and interpretation company, raised USD 23 in Series B funding. The round was led by Dunamu & Partners with participation from InterVest, Signite Partners, KC, and VNTG Corporation, as well as existing investors DSC Investment, Paratus Investment, and Schmidt.
Paratus Investment Investments
14 Investments
Paratus Investment has made 14 investments. Their latest investment was in AiV as part of their Series B on December 12, 2022.

Paratus Investment Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
12/29/2022 | Series B | AiV | $7.97M | Yes | 1 | |
5/18/2022 | Series B | UPPthera | $21.96M | Yes | 3 | |
4/28/2022 | Series B | Genome Insight | $23M | No | 4 | |
4/26/2022 | Series B | |||||
3/23/2022 | Series A |
Date | 12/29/2022 | 5/18/2022 | 4/28/2022 | 4/26/2022 | 3/23/2022 |
---|---|---|---|---|---|
Round | Series B | Series B | Series B | Series B | Series A |
Company | AiV | UPPthera | Genome Insight | ||
Amount | $7.97M | $21.96M | $23M | ||
New? | Yes | Yes | No | ||
Co-Investors | |||||
Sources | 1 | 3 | 4 |
Paratus Investment Portfolio Exits
2 Portfolio Exits
Paratus Investment has 2 portfolio exits. Their latest portfolio exit was Genome & Company on December 26, 2018.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
12/26/2018 | IPO | Public | 2 | ||
Date | 12/26/2018 | |
---|---|---|
Exit | IPO | |
Companies | ||
Valuation | ||
Acquirer | Public | |
Sources | 2 |